The auditor resignation is a material adverse signal for a micro-cap company already flagged with going-concern doubt. Traders should expect heightened volatility and potential selling pressure as the market prices in the risk of delayed filings and a possible OTC delisting. The next critical catalyst is the announcement of a successor auditor; any further delays in that process will amplify the bearish thesis.
Price Chart
Executive Summary
Regenerex Pharma's auditor, dbbmckennon, resigned effective August 31, 2026, after serving since 2017. The resignation is a significant red flag, especially given the company's prior going-concern qualification and its admission that it is behind on filing periodic reports. The company has not yet named a successor auditor, creating uncertainty about its financial reporting timeline and raising the risk of a potential delisting or covenant breach.
Key Facts
- Auditor dbbmckennon resigned effective August 31, 2026, after serving since 2017.
- The resignation was not due to a disagreement on accounting principles, but the auditor's prior reports included a going-concern explanatory paragraph.
- The company has not yet engaged a successor auditor and acknowledges it is behind on filing its periodic reports.
- The company is an emerging growth company trading on the OTC market.
Financial Impact
No specific financial figures provided in the filing. The primary impact is the heightened risk of delayed financial reporting, potential OTC delisting, and increased cost of capital.
Risk Factors
- Failure to timely file periodic reports could lead to SEC enforcement or OTC delisting.
- Inability to find a successor auditor could force the company to cease operations or seek a reverse merger.
- The going-concern qualification in prior audits suggests the company may face a liquidity crisis.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001472375-26-000217 |
| Exhibit: exhibit16-1.htm | 0001472375-26-000217 |
| Document: 0001472375-26-000217-index-headers.html | 0001472375-26-000217 |
| Document: 0001472375-26-000217-index.html | 0001472375-26-000217 |
| Document: 0001472375-26-000217.txt | 0001472375-26-000217 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 4, 2026 7w ago | 8-K | — | awaiting T+20 | — | — |
Sep 1, 2026 7w ago | 8-K | — | awaiting T+20 | — | — |
Jun 11, 2026 19w ago | 8-K | — | awaiting T+20 | — | — |
May 6, 2026 24w ago | 8-K | — | awaiting T+20 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers